905 related articles for article (PubMed ID: 12716249)
1. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
2. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
Ciapparelli A; Dell'Osso L; Pini S; Chiavacci MC; Fenzi M; Cassano GB
J Clin Psychiatry; 2000 May; 61(5):329-34. PubMed ID: 10847306
[TBL] [Abstract][Full Text] [Related]
3. Predictors of response in a sample of treatment-resistant psychotic patients on clozapine.
Ciapparelli A; Ducci F; Carmassi C; Carlini M; Paggini R; Catena M; Bottai M; Dell'Osso L
Eur Arch Psychiatry Clin Neurosci; 2004 Oct; 254(5):343-6. PubMed ID: 15365711
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
[TBL] [Abstract][Full Text] [Related]
6. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
8. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
Banov MD; Zarate CA; Tohen M; Scialabba D; Wines JD; Kolbrener M; Kim JW; Cole JO
J Clin Psychiatry; 1994 Jul; 55(7):295-300. PubMed ID: 8071290
[TBL] [Abstract][Full Text] [Related]
9. Clozapine for treatment-refractory mania.
Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
[TBL] [Abstract][Full Text] [Related]
10. Clozapine treatment in a population of adults with mental retardation.
Antonacci DJ; de Groot CM
J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
Díaz-Marsá M; Sánchez S; Rico-Villademoros F;
J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
[TBL] [Abstract][Full Text] [Related]
15. Clozapine in severe mood disorders.
Zarate CA; Tohen M; Baldessarini RJ
J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
[TBL] [Abstract][Full Text] [Related]
16. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.
Hummel B; Dittmann S; Forsthoff A; Matzner N; Amann B; Grunze H
Neuropsychobiology; 2002; 45 Suppl 1():37-42. PubMed ID: 11893876
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
Stewart M; DelBello MP; Versavel M; Keller D
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):635-40. PubMed ID: 20035581
[TBL] [Abstract][Full Text] [Related]
18. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.
Pillay SS; Stoll AL; Weiss MK; Tohen M; Zarate CA; Banov MD; Cole JO
Ann Clin Psychiatry; 1996 Mar; 8(1):1-5. PubMed ID: 8743641
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
[TBL] [Abstract][Full Text] [Related]
20. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
